Cardiovascular Diseases Clinical Trial
Official title:
Red Blood Cell ATP Release and Vascular Function in Humans
Previous work demonstrates that the red blood cells of older adults do not release a potent vasodilator (ATP) as well as the red blood cells of younger adults. The investigators are targeting a pathway within the red blood cell using fasudil hydrochloride to determine if both the release of ATP from red blood cells and blood flow responses to low oxygen (hypoxia) and exercise in older adults can be improved.
Participants will initiate contact with the investigators by responding to flyers placed in
the community either by phone or email. The first correspondence (phone or email) will
provide a brief description of the research and ask a series of screening questions to
determine age, height, weight, and any medications participants may be taking as well as the
current health status (diagnoses, basic health history, and physical activity level) of
participants. If they qualify, a two hour screening visit is scheduled during a time when the
participant will be examined by the physician. All participants will undergo informed consent
in a face to face private meeting with the research coordinator. Following informed consent,
participants will be evaluated by a physician and undergo a treadmill stress test to rule out
cardiovascular disease.
During the study, heart rate will be monitored with a 3-lead ECG and blood pressure will be
monitored noninvasively with a blood pressure cuff on the finger (finometry). Venous blood
will be collected at multiple time points via a catheter inserted into a forearm vein
draining skeletal muscle circulation for measurement of blood gases (0.5 mL/sample) and
plasma [ATP] (2 mL/sample), with less than 100 mL of blood being drawn in total (~60mL
total). Blood flow at rest and in response to hypoxia and exercise will be measured
non-invasively using Doppler ultrasound of the brachial artery. Hypoxia trials will be
performed by having participants breathe a low oxygen gas mixture via a mouthpiece that is
hooked up to gas tanks and an anesthesia monitor to decrease their oxygen saturation to ~80%
(similar to hiking a 14er) for 10 minutes. Exercise trials will last for approximately 15
minutes and will involve participants performing graded-intensity rhythmic handgrip exercise
by lifting weights (corresponding to a low, moderate, and high workload) using a pulley
system. The drug treatment used in this study (fasudil) is being given because it may improve
red blood cell ATP release in older adults. This is a double-blinded placebo controlled
study, thus participation will occur on two randomized experimental days.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|